{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:09:24Z","timestamp":1771546164038,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T00:00:00Z","timestamp":1752969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T00:00:00Z","timestamp":1752969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"],"award-info":[{"award-number":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"],"award-info":[{"award-number":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"],"award-info":[{"award-number":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"],"award-info":[{"award-number":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"],"award-info":[{"award-number":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"],"award-info":[{"award-number":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"],"award-info":[{"award-number":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"],"award-info":[{"award-number":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"],"award-info":[{"award-number":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"],"award-info":[{"award-number":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"],"award-info":[{"award-number":["SEI-260003\/019723\/2022, SEI-260003\/007043\/2022, SEI-260003\/003788\/2022, E-26\/210.403.2022, E-26\/201.303\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-11599-2","type":"journal-article","created":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T07:27:31Z","timestamp":1752996451000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Statine-based peptidomimetics as SARS-CoV-2 Papain-like protease inhibitors: in Silico and in vitro studies"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6982-8215","authenticated-orcid":false,"given":"Raiane Dandara Pereira","family":"Pimentel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4483-2119","authenticated-orcid":false,"given":"Priscila Goes","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2512-5267","authenticated-orcid":false,"given":"Pedro Henrique R.","family":"de A. Azevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4011-8532","authenticated-orcid":false,"given":"Larissa Esteves Carvalho","family":"Constant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1041-5627","authenticated-orcid":false,"given":"Stephany","family":"da Silva Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1410-480X","authenticated-orcid":false,"given":"Diego","family":"Allonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8453-7654","authenticated-orcid":false,"given":"Carlos Rangel","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1558-0928","authenticated-orcid":false,"given":"Magaly Gir\u00e3o","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5809-5602","authenticated-orcid":false,"given":"Luiza R. S.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8489-1848","authenticated-orcid":false,"given":"Estela Maris F.","family":"Muri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5579-7809","authenticated-orcid":false,"given":"Camilo Henrique","family":"da Silva Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,20]]},"reference":[{"key":"11599_CR1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1590\/s1677-5538.ibju.2020.s101","volume":"46","author":"M A Lauxmann","year":"2020","unstructured":"Lauxman, M. A. et al. The SARS-CoV-2 Coronavirus and the COVID-19 Outbreak. Int. Braz. J. Urol.\u00a046, 6\u201318 (2020).","journal-title":"Int Braz J Urol"},{"key":"11599_CR2","unstructured":"World Health Organization (WHO). Number of COVID-19 cases reported to WHO. (2024). https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c"},{"key":"11599_CR3","doi-asserted-by":"publisher","first-page":"e0272752","DOI":"10.1371\/journal.pone.0272752","volume":"18","author":"SRR Colonia","year":"2023","unstructured":"Colonia, S. R. R., Cardeal, L. M., de Oliveira, R. A. & Trinca, L. A. Assessing COVID-19 pandemic excess deaths in brazil: years 2020 and 2021. PLoS One. 18, e0272752 (2023).","journal-title":"PLoS One"},{"key":"11599_CR4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel, J. H. et al. Remdesivir for the treatment of Covid-19 \u2014 Final report. N Engl. J. Med. 383, 1813\u20131826 (2020).","journal-title":"N Engl. J. Med."},{"key":"11599_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa2116044","volume":"386","author":"A Jayk Bernal","year":"2022","unstructured":"Jayk Bernal, A. et al. Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients. N Engl. J. Med. 386, 509\u2013520 (2022).","journal-title":"N Engl. J. Med."},{"key":"11599_CR6","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1007\/s00044-022-02951-6","volume":"31","author":"RP Joyce","year":"2022","unstructured":"Joyce, R. P., Hu, V. W. & Wang, J. The history, mechanism, and perspectives of nirmatrelvir (PF-07321332): an orally bioavailable main protease inhibitor used in combination with Ritonavir to reduce COVID-19-related hospitalizations. Med. Chem. Res. 31, 1637\u20131646 (2022).","journal-title":"Med. Chem. Res."},{"key":"11599_CR7","doi-asserted-by":"publisher","first-page":"114367","DOI":"10.1016\/j.biopha.2023.114367","volume":"162","author":"SMR Hashemian","year":"2023","unstructured":"Hashemian, S. M. R. et al. Paxlovid (Nirmatrelvir\/Ritonavir): A new approach to Covid-19 therapy? Biomed. Pharmacother. 162, 114367 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"11599_CR8","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/infdis\/jiad195","volume":"228","author":"AA Butt","year":"2023","unstructured":"Butt, A. A. et al. Molnupiravir use and 30-Day hospitalizations or death in a previously uninfected nonhospitalized High-risk population with COVID-19. J. Infect. Dis. 228, 1033\u20131041 (2023).","journal-title":"J. Infect. Dis."},{"key":"11599_CR9","doi-asserted-by":"crossref","unstructured":"Al-Karmalawy, A. A. et al. Molecular Docking and dynamics simulation revealed the potential inhibitory activity of aceis against SARS-CoV-2 targeting the hACE2 receptor. Front Chem 9, 661230 (2021).","DOI":"10.3389\/fchem.2021.661230"},{"key":"11599_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/pharmaceutics16020169","volume":"16","author":"S Kralj","year":"2024","unstructured":"Kralj, S. et al. Identification of Triazolopyrimidinyl scaffold SARS-CoV-2 Papain-Like protease (PLpro) inhibitor. Pharmaceutics 16, 169 (2024).","journal-title":"Pharmaceutics"},{"key":"11599_CR11","unstructured":"Klemm, T. et al. Mechanism and Inhibition of the papain-like protease, plpro, of SARS\u2010CoV\u20102. EMBO J 39, e106275 (2020)."},{"key":"11599_CR12","doi-asserted-by":"publisher","first-page":"138068","DOI":"10.1016\/j.cplett.2020.138068","volume":"761","author":"M Alfaro","year":"2020","unstructured":"Alfaro, M., Alfaro, I. & Angel, C. Identification of potential inhibitors of SARS-CoV-2 papain-like protease from tropane alkaloids from Schizanthus porrigens: A molecular Docking study. Chem. Phys. Lett. 761, 138068 (2020).","journal-title":"Chem. Phys. Lett."},{"key":"11599_CR13","doi-asserted-by":"publisher","first-page":"16119","DOI":"10.1073\/pnas.0805240105","volume":"105","author":"K Ratia","year":"2008","unstructured":"Ratia, K. et al. A noncovalent class of papain-like protease\/deubiquitinase inhibitors blocks SARS virus replication. Proc. Natl. Acad. Sci. 105, 16119\u201316124 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"11599_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","volume":"587","author":"D Shin","year":"2020","unstructured":"Shin, D. et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature 587, 657\u2013662 (2020).","journal-title":"Nature"},{"key":"11599_CR15","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/s41467-020-20718-8","volume":"12","author":"Z Fu","year":"2021","unstructured":"Fu, Z. et al. The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery. Nat. Commun. 12, 488 (2021).","journal-title":"Nat. Commun."},{"key":"11599_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","volume":"12","author":"J Osipiuk","year":"2021","unstructured":"Osipiuk, J. et al. Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors. Nat. Commun. 12, 743 (2021).","journal-title":"Nat. Commun."},{"key":"11599_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41589-020-00689-z","volume":"17","author":"W Rut","year":"2021","unstructured":"Rut, W. et al. SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging. Nat. Chem. Biol. 17, 222\u2013228 (2021).","journal-title":"Nat. Chem. Biol."},{"key":"11599_CR18","doi-asserted-by":"publisher","unstructured":"de Azevedo, P. H. R. Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV\u20132 Mpro). Sci. Rep. 1\u201316 https:\/\/doi.org\/10.1038\/s41598-024-59442-4 (2024).","DOI":"10.1038\/s41598-024-59442-4"},{"key":"11599_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cbpa.2008.03.009","volume":"12","author":"J Vagner","year":"2008","unstructured":"Vagner, J., Qu, H. & Hruby, V. J. Peptidomimetics, a synthetic tool of drug discovery. Curr. Opin. Chem. Biol. 12, 292\u2013296 (2008).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"11599_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1590\/S0100-40421997000300011","volume":"20","author":"EJ Barreiro","year":"1997","unstructured":"Barreiro, E. J., Rodrigues, C. R., Albuquerque, M. G., de Sant\u2019Anna, C. M. R. & Alencastro, R. B. de. Modelagem molecular: Uma ferramenta Para o Planejamento racional de F\u00e1rmacos Em Qu\u00edmica medicinal. Quim. Nova. 20, 300\u2013310 (1997).","journal-title":"Quim. Nova"},{"key":"11599_CR21","doi-asserted-by":"publisher","unstructured":"Silakari, O. & Singh, P. K. Fundamentals of molecular modeling. in Concepts and Experimental Protocols of Modelling and Informatics in Drug Design 1\u201327 (Elsevier, doi:https:\/\/doi.org\/10.1016\/B978-0-12-820546-4.00001-5. (2021).","DOI":"10.1016\/B978-0-12-820546-4.00001-5"},{"key":"11599_CR22","doi-asserted-by":"crossref","unstructured":"Henderson, J. A., Verma, N., Harris, R. C., Liu, R. & Shen, J. Assessment of proton-coupled conformational dynamics of SARS and MERS coronavirus papain-like proteases: implication for designing broad-spectrum antiviral inhibitors. J Chem. Phys 153, 181305 (2020).","DOI":"10.1063\/5.0020458"},{"key":"11599_CR23","doi-asserted-by":"publisher","first-page":"11140","DOI":"10.1002\/anie.201405820","volume":"53","author":"DA Evans","year":"2014","unstructured":"Evans, D. A. History of the Harvard ChemDraw project. Angew Chemie - Int. Ed. 53, 11140\u201311145 (2014).","journal-title":"Angew Chemie - Int. Ed."},{"key":"11599_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/prot.10465","volume":"52","author":"ML Verdonk","year":"2003","unstructured":"Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W. & Taylor, R. D. Improved protein-ligand Docking using GOLD. Proteins Struct. Funct. Bioinforma. 52, 609\u2013623 (2003).","journal-title":"Proteins Struct. Funct. Bioinforma"},{"key":"11599_CR25","first-page":"82","volume":"40","author":"WL DeLano","year":"2002","unstructured":"DeLano, W. L. & Pymol An open-source molecular graphics tool. CCP4 Newsl. Protein Crystallogr. 40, 82\u201392 (2002).","journal-title":"CCP4 Newsl. Protein Crystallogr."},{"key":"11599_CR26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","volume":"GROMACS","author":"MJ Abraham","year":"2015","unstructured":"Abraham, M. J. et al. High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1\u20132. GROMACS, 19\u201325 (2015).","journal-title":"SoftwareX 1\u20132"},{"key":"11599_CR27","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jcc.23354","volume":"34","author":"J Huang","year":"2013","unstructured":"Huang, J. & MacKerell, A. D. CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data. J. Comput. Chem. 34, 2135\u20132145 (2013).","journal-title":"J. Comput. Chem."},{"key":"11599_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/pro.3280","volume":"27","author":"E Jurrus","year":"2018","unstructured":"Jurrus, E. et al. Improvements to the APBS biomolecular solvation software suite. Protein Sci. 27, 112\u2013128 (2018).","journal-title":"Protein Sci."},{"key":"11599_CR29","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1002\/jcc.23067","volume":"33","author":"W Yu","year":"2012","unstructured":"Yu, W., He, X., Vanommeslaeghe, K. & MacKerell, A. D. Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations. J. Comput. Chem. 33, 2451\u20132468 (2012).","journal-title":"J. Comput. Chem."},{"key":"11599_CR30","unstructured":"Gomes, D. E. B., da Silva, A. W., Lins, R. D. & Pascutti, P. G. & A., S. HbMap2Grace. Software for mapping the hydrogen bond frequency. Lab Mol. Model. Dyn (2009)."},{"key":"11599_CR31","unstructured":"Turner, P. J. & XMGRACE Version 5.1.19. Center for Coastal and Land-Margin Research (Oregon Graduate Institute of Science and Technology, 2005)."},{"key":"11599_CR32","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1021\/ci500020m","volume":"54","author":"R Kumari","year":"2014","unstructured":"Kumari, R., Kumar, R. & Lynn, A. g_mmpbsa \u2014A GROMACS tool for High-Throughput MM-PBSA calculations. J. Chem. Inf. Model. 54, 1951\u20131962 (2014).","journal-title":"J. Chem. Inf. Model."},{"key":"11599_CR33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33\u201338 (1996).","journal-title":"J. Mol. Graph"},{"key":"11599_CR34","doi-asserted-by":"publisher","first-page":"108925","DOI":"10.1016\/j.jmgm.2024.108925","volume":"135","author":"M Sardar","year":"2025","unstructured":"Sardar, M. et al. Unraveling Interleukin-1\u03b2 inhibition: computational insights into anti-inflammatory compound selection for inflammatory disorders. J. Mol. Graph Model. 135, 108925 (2025).","journal-title":"J. Mol. Graph Model."},{"key":"11599_CR35","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1080\/07391102.2023.2231546","volume":"42","author":"B Ferrari","year":"2024","unstructured":"Ferrari, B., de Lima, S., Albuquerque, M. G. & C. H. da S. & Development, validation and analysis of a human profurin 3D model using comparative modeling and molecular dynamics simulations. J. Biomol. Struct. Dyn. 42, 5428\u20135446 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"11599_CR36","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.1021\/acs.jctc.9b00454","volume":"15","author":"AM Westerlund","year":"2019","unstructured":"Westerlund, A. M., Delemotte, L. & InfleCS Clustering free energy landscapes with Gaussian mixtures. J. Chem. Theory Comput. 15, 6752\u20136759 (2019).","journal-title":"J. Chem. Theory Comput."},{"key":"11599_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1021\/acs.jctc.7b00346","volume":"14","author":"AM Westerlund","year":"2018","unstructured":"Westerlund, A. M., Harpole, T. J., Blau, C. & Delemotte, L. Inference of calmodulin\u2019s Ca 2+ -Dependent free energy landscapes via Gaussian mixture model validation. J. Chem. Theory Comput. 14, 63\u201371 (2018).","journal-title":"J. Chem. Theory Comput."},{"key":"11599_CR38","doi-asserted-by":"crossref","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 Adv. Drug Deliv. Rev. 46, 3\u201326 (2001). (1997).","DOI":"10.1016\/S0169-409X(00)00129-0"},{"key":"11599_CR39","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber, D. F. et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615\u20132623 (2002).","journal-title":"J. Med. Chem."},{"key":"11599_CR40","doi-asserted-by":"publisher","first-page":"W422","DOI":"10.1093\/nar\/gkae236","volume":"52","author":"L Fu","year":"2024","unstructured":"Fu, L. et al. ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support. Nucleic Acids Res. 52, W422\u2013W431 (2024).","journal-title":"Nucleic Acids Res."},{"key":"11599_CR41","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1021\/ci800305f","volume":"49","author":"T Sander","year":"2009","unstructured":"Sander, T., Freyss, J., von Korff, M., Reich, J. R. & Rufener, C. OSIRIS, an entirely in-House developed drug discovery informatics system. J. Chem. Inf. Model. 49, 232\u2013246 (2009).","journal-title":"J. Chem. Inf. Model."},{"key":"11599_CR42","unstructured":"CCDC Software Ltd. GOLD user guide. (2022). https:\/\/www.ccdc.cam.ac.uk\/media\/Documentation\/0C5D99BC-7CC3-49B6-8319-06BEA8CA342D\/GOLD_User_Guide_2020_1.pdf"},{"key":"11599_CR43","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1021\/ci050141q","volume":"46","author":"G Bottegoni","year":"2006","unstructured":"Bottegoni, G., Cavalli, A. & Recanatini, M. A. Comparative study on the application of Hierarchical\u2009\u2013\u2009Agglomerative clustering approaches to organize outputs of reiterated Docking runs. J. Chem. Inf. Model. 46, 852\u2013862 (2006).","journal-title":"J. Chem. Inf. Model."},{"key":"11599_CR44","doi-asserted-by":"publisher","first-page":"106449","DOI":"10.1016\/j.compbiomed.2022.106449","volume":"153","author":"RS Tumskiy","year":"2023","unstructured":"Tumskiy, R. S., Tumskaia, A. V., Klochkova, I. N. & Richardson, R. J. SARS-CoV-2 proteases Mpro and plpro: design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations. Comput. Biol. Med. 153, 106449 (2023).","journal-title":"Comput. Biol. Med."},{"key":"11599_CR45","doi-asserted-by":"publisher","first-page":"6728","DOI":"10.1080\/07391102.2020.1802341","volume":"39","author":"T Joshi","year":"2021","unstructured":"Joshi, T. et al. Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease. J. Biomol. Struct. Dyn. 39, 6728\u20136746 (2021).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"11599_CR46","unstructured":"David, C. C. & Jacobs, D. J. Protein Dynamicsvol. 1084 (Humana, 2014)."},{"key":"11599_CR47","doi-asserted-by":"crossref","unstructured":"Ewert, W. et al. Hydrazones and thiosemicarbazones targeting Protein-Protein-Interactions of SARS-CoV-2 Papain-like protease. Front Chem 10, 832431 (2022).","DOI":"10.3389\/fchem.2022.832431"},{"key":"11599_CR48","doi-asserted-by":"publisher","first-page":"107821","DOI":"10.1016\/j.jbc.2024.107821","volume":"300","author":"JC Ferreira","year":"2024","unstructured":"Ferreira, J. C. et al. Identification of novel allosteric sites of SARS-CoV-2 papain-like protease (PLpro) for the development of COVID-19 antivirals. J. Biol. Chem. 300, 107821 (2024).","journal-title":"J. Biol. Chem."},{"key":"11599_CR49","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s42003-022-03737-7","volume":"5","author":"V Srinivasan","year":"2022","unstructured":"Srinivasan, V. et al. Antiviral activity of natural phenolic compounds in complex at an allosteric site of SARS-CoV-2 papain-like protease. Commun. Biol. 5, 805 (2022).","journal-title":"Commun. Biol."},{"key":"11599_CR50","doi-asserted-by":"crossref","unstructured":"Calleja, D. J., Lessene, G. & Komander, D. Inhibitors of SARS-CoV-2 PLpro. Front Chem 10, 876212 (2022).","DOI":"10.3389\/fchem.2022.876212"},{"key":"11599_CR51","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1021\/acsinfecdis.2c00091","volume":"8","author":"AC Puhl","year":"2022","unstructured":"Puhl, A. C. et al. Pyronaridine protects against SARS-CoV-2 infection in mouse. ACS Infect. Dis. 8, 1147\u20131160 (2022).","journal-title":"ACS Infect. Dis."},{"key":"11599_CR52","doi-asserted-by":"publisher","first-page":"22603","DOI":"10.1021\/acsomega.3c01110","volume":"8","author":"AC Puhl","year":"2023","unstructured":"Puhl, A. C. et al. Discovery of PL pro and M pro inhibitors for SARS-CoV-2. ACS Omega. 8, 22603\u201322612 (2023).","journal-title":"ACS Omega"},{"key":"11599_CR53","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.2174\/0929867325666171129121924","volume":"26","author":"S Vilar","year":"2019","unstructured":"Vilar, S., Sobarzo-S\u00e1nchez, E. & Uriarte, E. Silico prediction of P-glycoprotein binding: insights from molecular Docking studies. Curr. Med. Chem. 26, 1746\u20131760 (2019).","journal-title":"Curr. Med. Chem."},{"key":"11599_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00008571-199602000-00002","volume":"6","author":"DR Nelson","year":"1996","unstructured":"Nelson, D. R. et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6, 1\u201342 (1996).","journal-title":"Pharmacogenetics"},{"key":"11599_CR55","doi-asserted-by":"crossref","unstructured":"Cho, H. et al. In vitro metabolic characterization of the SARS-CoV-2 papain-like protease inhibitors GRL0617 and HY-17542. Front Pharmacol 14, 1067408 (2023).","DOI":"10.3389\/fphar.2023.1067408"},{"key":"11599_CR56","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2174\/156802609788317829","volume":"9","author":"L Du","year":"2009","unstructured":"Du, L., Li, M. & You, Q. The interactions between hERG potassium channel and blockers. Curr. Top. Med. Chem. 9, 330\u2013338 (2009).","journal-title":"Curr. Top. Med. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11599-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11599-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11599-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T17:04:37Z","timestamp":1757264677000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-11599-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,20]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11599"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-11599-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,20]]},"assertion":[{"value":"1 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare that the research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"26319"}}